山东威高集团医用高分子制品股份有限公司（01066.HK）于2026年2月10日发布翌日披露报表，公告当日购回6.16万股H股股份，约占公司已发行股本的0.0014%。回购价格介乎每股港币5.24元至5.27元，涉资约港币32.4万元。
根据公告，此次回购完成后，公司已发行股份总数为4,481,322,324股，库藏股数增至41,010,000股。公司在2025年5月27日获股东大会通过回购授权，授权总额为451,560,392股，截至目前累计回购34,361,600股，占授权通过时已发行股本约7.6095%。该公司确认已遵守上市规则及相关法规程序，公告由公司秘书黄妙玲签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.